RCPA · Royal College of Pathologists of Australasia; Anatomical Pathology Fellowship
RCPA AP / diagnose it.
Written exam grader with RCPA examiner-style marking, glass slide viva simulator with IHC panel construction and tumour grading, spaced-repetition flashcards, and sourced study notes across all 237 anatomical pathology curriculum learning objectives. Built for the precision the RCPA fellowship demands.
Pass rate
~60%
per sitting (combined components)
Sittings per year
1–2
Part I and Part II annually
Format
Written + Practical + Viva
Part I: MCQ + SAQ · Part II: clinical scenarios · Practical: glass slides · Viva
Topics covered
131
study notes · 237 LOs
Organising college
RCPA
Not affiliated with Primex
· Exam domains ·
Four pathology domains.
From specimen bench to viva room.
From specimen bench to viva room.
~30%
Surgical Pathology & Tumour Classification
Lung IHC panels (adenocarcinoma TTF-1/Napsin A vs SCC p40/CK5/6 vs SCLC synaptophysin/chromogranin), colorectal carcinoma MSI/MMR testing and Lynch syndrome, breast biomarkers (ER Allred, HER2 3+ or FISH ratio ≥2, Ki67), prostate Gleason/ISUP Grade Groups (GG1=6 → GG5=9-10), WHO 2021 CNS classification (IDH wild-type GBM: TERT/EGFR/+7/-10), endometrial TCGA molecular subtypes.
TTF-1 vs p40 · ER Allred scoring · Gleason/ISUP · IDH wild-type GBM criteria · TCGA endometrial · GIST (CD117/DOG1)
~25%
Immunohistochemistry & Molecular Diagnostics
IHC panel construction (minimum 3-marker panels with positive and negative controls), FISH indications (HER2 dual ISH, MDM2 liposarcoma, ALK/ROS1, MYC/BCL2/BCL6, 1p/19q glioma, ploidy for POC), PCR for somatic variants (BRAF V600E, IDH1, EGFR, KRAS), HPV genotyping, NGS, and MRD monitoring.
HER2 FISH dual ISH · ALK/ROS1 FISH · BRAF V600E IHC/PCR · MMR panel (MLH1/MSH2/MSH6/PMS2) · IDH1 R132H IHC
~25%
Organ System Pathology
Skin (melanoma: Breslow depth, mitotic count, Clark level, BRAF V600E reflex for pT1b+), liver (HCC: HepPar-1/Arginase-1/GPC-3, FNH vs hepatocellular adenoma), mesothelioma (calretinin/WT-1/CK5/6/D2-40 positive; CEA/CD15/MOC-31/BerEP4 negative), thyroid (TIRADS, papillary carcinoma nuclear features), lymphoma IHC (DLBCL vs Hodgkin vs metastatic; CD20/CD3/CD30/CD15/AE1-AE3/SOX11 minimum panel).
Breslow + mitotic count · Mesothelioma vs adenocarcinoma · HCC vs FNH · Lymphoma minimum panel · Papillary carcinoma nuclei
~20%
Laboratory Management, Frozen Section & Reporting
RCPA structured synoptic reporting protocols (cancer), frozen section limitations and intraoperative communication, cut-up and block selection, specimen management (FNA adequacy, SNOMED CT/LOINC coding), QA and digital pathology/AI integration, medicolegal reporting obligations, cultural safety in pathology practice.
Frozen section limitations · Synoptic reporting · FNA adequacy · SNOMED CT · Complete vs partial mole (p57) · Intraoperative communication
· Feature 01 · Written Exam Grader
MCQ and clinical scenario feedback at RCPA examiner standard.
The RCPA Anatomical Pathology Part I Written combines MCQ (4 options, single best answer) and SAQs on general pathology principles and IHC interpretation. Part II features extended clinical scenarios with histological descriptions requiring WHO-classified diagnosis, IHC panel construction, and management. Primex grades responses for specific IHC marker combinations, numerical staging thresholds, and correct tumour classification; the errors RCPA examiners most commonly cite.
- Part I MCQ and SAQ grading with IHC marker combination feedback
- Part II clinical scenario feedback: histological description → differential → IHC panel → diagnosis → management
- Common errors flagged: p63 vs p40 confusion (p40 is superior for squamous), missing synchronous carcinoma in adenoma, FAB vs WHO terminology
- Numerical thresholds checked: Gleason/ISUP grade groups, Breslow depth cut-offs, Nottingham grade elements
· Feature 02 · Flashcards
237 LOs. Spaced repetition for IHC panels and tumour classification.
RCPA AP requires precision on IHC panel construction, tumour grading criteria, and molecular markers. Primex flashcards are designed around the specific recall format the viva demands: "What is your IHC panel for X?" and "What result would confirm your diagnosis?"
- IHC panel cards: primary lung (TTF-1/Napsin A/p40/CK5-6/synaptophysin/CD56/INSM1), mesothelioma, metastatic carcinoma differentials, lymphoma minimum panels
- Tumour grading cards: Gleason/ISUP (GG1–5), Nottingham Grade (tubules/nuclei/mitoses 3+3+3), Breslow depth thresholds, WHO CNS 2021 grade criteria
- Molecular marker cards: MSI vs microsatellite stable, IDH1/2 mutation implications, 1p/19q co-deletion for oligodendroglioma, POLE ultramutated endometrial
- Staging cards: AJCC 8e pT/pN staging for lung, colorectal, breast, prostate, melanoma
· Feature 03 · Viva Simulator
Glass slides. Frozen sections. The full RCPA AP viva.
The RCPA AP Viva presents histological descriptions (or glass slide scenarios) and expects a systematic report approach: specimen type → macroscopic → microscopic → IHC → molecular → integrated WHO-classified diagnosis → clinicopathological correlation. Primex's viva simulator replicates this exactly; presenting histological descriptions and probing at every step.
- Systematic viva structure: specimen → macroscopic → microscopic → IHC → molecular → diagnosis → correlation
- High-yield scenarios: lung biopsy (primary vs metastatic), lymph node biopsy (DLBCL vs Hodgkin vs reactive vs metastatic carcinoma), prostate needle core (systematic Gleason grading per core), frozen section thyroid (when to defer vs proceed)
- Examiner probes: "What additional stain would you perform and what result would confirm your diagnosis?"
- Frozen section communication: how to report findings to surgeons and communicate limitations
· Feature 04 · Study Notes
131 topics. Every RCPA anatomical pathology curriculum domain mapped.
Every Primex RCPA AP study note follows a structured format: pathophysiology/biology, WHO classification, IHC panel with specific markers, molecular features, staging criteria, and reporting implications. Each note maps to its RCPA Trainee Handbook 2025 curriculum LO.
- 131 topics covering the full RCPA AP curriculum; surgical pathology, IHC/molecular, organ systems, laboratory management
- WHO classification criteria with specific numerical thresholds in every relevant note
- IHC panel tables: markers, expected results, and positive/negative controls
- References to WHO Blue Books (CNS 2021, Digestive System 2019, Thoracic Tumours 2021), RCPA structured reporting protocols, and AJCC 8e staging
· Feature 05 · RCPA Curriculum Tracker
237 learning objectives. Progress across all 7 curriculum domains.
The RCPA Anatomical Pathology Trainee Handbook (January 2025) defines 237 LOs across 7 domains including discipline-specific (Sections 1.1–1.5), laboratory management (2), research (3), and professional qualities (4). Primex maps every LO with per-domain progress tracking.
- All 237 RCPA AP LOs mapped across 7 curriculum domains
- Appendix 13 Molecular Competencies tracked separately (FISH, IHC for oncoproteins, PCR for somatic variants)
- Checkbox completion persisted to localStorage
- Per-domain progress bars showing Part I, Part II, and viva coverage
· About this exam ·
The RCPA Anatomical Pathology Fellowship Examination
The RCPA Anatomical Pathology Fellowship Examination is conducted by the Royal College of Pathologists of Australasia. It comprises Part I Written (MCQ and SAQ on general and organ system pathology, IHC interpretation, and tumour classification), Part II Written (extended clinical scenarios with histological descriptions requiring integrated diagnosis and management), a Practical (glass slide interpretation with systematic reporting), and a Viva.
The Viva presents histological scenarios with clinical context and requires candidates to demonstrate a systematic reporting approach; from specimen type and macroscopic description through microscopic features, IHC construction, molecular testing, and WHO-classified diagnosis to clinicopathological correlation and management implications. The 2025 curriculum explicitly includes Appendix 13 Molecular Competencies covering FISH, IHC for oncoproteins, and PCR for somatic variants.
- OrganiserRoyal College of Pathologists of Australasia (RCPA)
- Part I WrittenMCQ (4-option, single best answer) + SAQ; general and organ system pathology, IHC
- Part II WrittenExtended clinical scenarios; histological description → differential → IHC → diagnosis → management
- PracticalGlass slide systematic interpretation with RCPA structured synoptic reporting protocols
- VivaHistological scenarios requiring systematic report approach with clinicopathological correlation
- CurriculumRCPA AP Trainee Handbook January 2025; 237 LOs across 7 domains including Appendix 13 Molecular Competencies
· Key resources ·
- WHO Classification of Tumours series (Blue Books); CNS 2021, Digestive System 2019, Thoracic 2021, Breast 2022; classification gold standards
- RCPA Structured Pathology Reporting of Cancer protocols (rcpa.edu.au); synoptic reporting reference
- AJCC Cancer Staging Manual (8e); pT/pN staging reference
- Rosai and Ackerman's Surgical Pathology (11e); comprehensive surgical pathology reference
- Diagnostic Immunohistochemistry (Dabbs, 5e); IHC panel reference
- RCPA Trainee Handbook 2025; curriculum LOs and Appendix 13 Molecular Competencies
- College of American Pathologists (CAP) Protocols; international synoptic reporting reference
· Pricing ·
Every plan starts with
a 7-day free trial.
a 7-day free trial.
Starter
$9.99
7 days free, then $9.99/mo
- ✓ One specialist exam (your choice)
- ✓ Study notes for every curriculum topic
- ✓ Flashcards with spaced repetition
- ✓ 10 MCQs per topic (sampler)
- ✓ Study plan with pace tracking
- ✗ AI viva simulation & voice mode
- ✗ MCQ drill mode
- ✗ SAQ question bank & sessions
- ✗ Community feed
Monthly
$24.99
7 days free, then $24.99/mo
- ✓ All 21 specialist exams: SAQ, MCQ, Viva & Voice
- ✓ Flashcards with spaced repetition & MCQ drill
- ✓ Study notes for every curriculum topic
- ✓ SAQ question bank & sessions
- ✓ Study plan with pace tracking
- ✓ Community feed
3 Months
$59.99
7 days free, then $59.99/3mo
= $19.99/mo · save 20% vs monthly
- ✓ All 21 specialist exams: SAQ, MCQ, Viva & Voice
- ✓ Flashcards with spaced repetition & MCQ drill
- ✓ Study notes for every curriculum topic
- ✓ SAQ question bank & sessions
- ✓ Study plan with pace tracking
- ✓ Save 20% vs monthly
Best Value
Yearly
$15.00
per month, billed $179.99/yr
= $15/mo · save 40% vs monthly
- ✓ All 21 specialist exams: SAQ, MCQ, Viva & Voice
- ✓ Flashcards with spaced repetition & MCQ drill
- ✓ Study notes for every curriculum topic
- ✓ SAQ question bank & sessions
- ✓ Study plan with pace tracking
- ✓ Save 40% vs monthly plan
Important: Step 2 of 2
After payment, you'll land on a confirmation page. Click the button there to create your account and your subscription links automatically. If you pay with Apple Pay or Google Pay, use the button on that confirmation page before closing it. No email matching needed; it connects via a one-time link.
Free trial on every plan (7 days)
Cancel anytime before trial ends
Not affiliated with RCPA
· FAQ ·
Common questions
The examination consists of: Part I Written (MCQ + SAQ covering general pathology, organ system pathology, IHC, and tumour classification), Part II Written (extended clinical scenarios integrating histological descriptions with diagnosis and management), Practical (glass slide interpretation with systematic reporting), and Viva (histological scenarios requiring systematic report approach and clinicopathological correlation). Candidates must pass Part I before sitting Part II.
The minimum panel is TTF-1, Napsin A, p40, and CK5/6. Adenocarcinoma: TTF-1 positive/Napsin A positive/p40 negative/CK5-6 negative. Squamous cell carcinoma: p40 positive/CK5-6 positive/TTF-1 negative/Napsin A negative. For SCLC: synaptophysin, chromogranin, CD56/INSM1 positive. If metastasis is suspected, add CK7/CK20 and site-specific markers (CDX2 for colorectal, ER/GATA3 for breast). A common RCPA examiner error is using p63 instead of p40; p63 can also stain myoepithelial and urothelial cells and is therefore less specific.
The ISUP Grade Group system replaced Gleason scoring: GG1 = Gleason 6 (3+3), GG2 = Gleason 3+4=7, GG3 = Gleason 4+3=7, GG4 = Gleason 8 (4+4, 3+5, or 5+3), GG5 = Gleason 9–10. Critical reporting elements per RCPA protocol: Grade Group per core, percentage of core involved, percentage of Gleason pattern 4 (for GG2/3), tertiary pattern if >5% of cancer, presence of perineural invasion, extracapsular extension. RCPA examiner reports note candidates who report Gleason 3+3=6 as "well differentiated"; the grade simply indicates the lowest ISUP group, not true well-differentiation.
Frozen section limitations include: (1) Follicular thyroid lesions; capsular invasion is difficult to assess on frozen, defer to paraffin; (2) Lymphoma classification; cannot be made on frozen alone without flow cytometry and IHC; (3) Small biopsies; freezing artefact may obscure diagnostic features; (4) Fatty tissue; fat artefact on frozen is severe. When reporting frozen sections to surgeons (RCPA curriculum Section 1.5.4), candidates must communicate both the diagnosis and its limitations; "consistent with" versus "confirmed"; and indicate when a deferred diagnosis is necessary.
Appendix 13 (RCPA AP Trainee Handbook 2025) specifies the molecular tests candidates must know how to order, interpret, and act on: IHC for MMR proteins (MLH1/MSH2/MSH6/PMS2), BRAF V600E, IDH1 R132H, ATRX, TP53, p16, SDH; Dual ISH for HER2 (MBS 73332/73342), ISH for MDM2 in liposarcoma (73374), FISH for ALK/ROS1 (73341/73344), FISH for MYC/BCL2/BCL6/CCND1 in lymphoma, ISH for 1p/19q in glioma (73371), ploidy ISH for products of conception (73389); PCR for BRAF V600E, IDH1 R132H, EGFR, and KRAS somatic variants; HPV genotyping (73070-73075).
Complete hydatidiform mole: androgenetic diploid (46,XX or 46,XY), no fetal tissue, diffuse villous hydrops, diffuse trophoblast proliferation, p57 immunostaining absent (p57 is a paternally imprinted, maternally expressed gene; absent in complete mole). Partial mole: typically triploid (69,XXX or 69,XXY), fetal tissue present, focal villous changes, p57 positive. FISH for ploidy (73389) confirms triploidy in partial moles. A common error is failing to perform p57 as part of the initial workup for a suspected molar pregnancy; the RCPA examiners note this explicitly.
Yes. Primex includes RCPA Haematology as a separate exam section (129 topics, 645 LOs) covering malignant haematology, coagulation, red cell disorders, transfusion medicine, and bone marrow interpretation. Monthly, Quarterly, and Yearly subscriptions include all 21 exams; both RCPA Anatomical Pathology and RCPA Haematology are accessible on a single subscription.
· Other exams on Primex ·
20 more fellowships covered
ANZCA Primary
Primary Examination
Anaesthesia basic sciences SAQ + viva
ANZCA Fellowship
Fellowship Examination
Clinical anaesthesia fellowship
CICM First Part
First Part Examination
Intensive care basic sciences
CICM Fellowship
Fellowship Examination
Critical care fellowship
ACEM Primary
Primary Examination
Emergency medicine basic sciences
ACEM Fellowship
Fellowship Examination
Emergency medicine fellowship
RACP BPT
Basic Physician Training
Internal medicine written + clinical
FRACP DCE
Divisional Clinical Examination
Physician advanced training clinical
FRACP Paeds
Paediatrics Clinical Exam
Paediatric physician fellowship
RACGP FRACGP
Fellowship Examination
General practice AKT · KFP · CCE
ACRRM FACRRM
Fellowship Examination
Rural and remote medicine StAMPS
RANZCP
Fellowship Examination
Psychiatry MEQ + CCA-MPR
FRANZCOG
Fellowship Examination
Obstetrics and gynaecology SAQ + OSCE
RANZCR Part 1
Part 1 Examination
Radiology physics + anatomy
RANZCR Part 2
Part 2 Fellowship
Clinical radiology viva + case reporting
AMC
AMC Examination
Medical registration MCQ + OSCE
RACS GSSE
General Surgical Science Exam
Written MCQ + anatomy spots
FRACS GS
General Surgery Fellowship
SAQ · Spots · 5 viva stations
FRACS Ortho
Orthopaedic Surgery Fellowship
Written + 4 viva stations
RCPA Haem
Haematology Fellowship
Haematology fellowship